Flying Forms interviews Brad Burge of MAPS about results from the growing field of psychedelic research. The interview focuses on the difference between treating PTSD with MDMA-assisted psychotherapy versus other treatments, the process of conducting research with criminalized substances, and the benefits of psychedelic-assisted therapy. Burge highlights how psychedelic research can be applied outside of medical contexts, noting that previous LSD studies helped pave the way for neuroscientists to better understand how serotonin works within the brain.
Listen to the interview here.
An interview with Brad Burge, Director of Communications and Marketing at MAPS (Multidisciplinary Association for Psychedelic Studies). Host Rabia Yeaman talks with Brad about the latest studies and breakthroughs in psychedelic treatment studies, and the future of LSD, MDMA and other psychedelics being studied to treat end of life issues and long-term PTSD.
